101 related articles for article (PubMed ID: 17669216)
1. Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses.
Robinson TM; Sidhu MK; Pavlakis GN; Felber BK; Silvera P; Lewis MG; Eldridge J; Weiner DB; Boyer JD
J Med Primatol; 2007 Aug; 36(4-5):276-84. PubMed ID: 17669216
[TBL] [Abstract][Full Text] [Related]
2. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
3. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques.
Boyer JD; Robinson TM; Kutzler MA; Parkinson R; Calarota SA; Sidhu MK; Muthumani K; Lewis M; Pavlakis G; Felber B; Weiner D
J Med Primatol; 2005 Oct; 34(5-6):262-70. PubMed ID: 16128921
[TBL] [Abstract][Full Text] [Related]
4. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
5. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
6. Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques.
Yan J; Hokey DA; Morrow MP; Corbitt N; Harris K; Harris D; Weiner DB
Vaccine; 2009 May; 27(25-26):3260-6. PubMed ID: 19200811
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
8. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.
Calarota SA; Hokey DA; Dai A; Jure-Kunkel MN; Balimane P; Weiner DB
Vaccine; 2008 Jun; 26(25):3121-34. PubMed ID: 18336959
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge.
Polacino P; Cleveland B; Zhu Y; Kimata JT; Overbaugh J; Anderson D; Hu SL
J Med Primatol; 2007 Aug; 36(4-5):254-65. PubMed ID: 17669214
[TBL] [Abstract][Full Text] [Related]
11. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.
Nakaya Y; Nakaya T; Park MS; Cros J; Imanishi J; Palese P; García-Sastre A
J Virol; 2004 Sep; 78(17):9366-75. PubMed ID: 15308731
[TBL] [Abstract][Full Text] [Related]
12. Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol.
Someya K; Ami Y; Nakasone T; Izumi Y; Matsuo K; Horibata S; Xin KQ; Yamamoto H; Okuda K; Yamamoto N; Honda M
J Immunol; 2006 Feb; 176(3):1784-95. PubMed ID: 16424209
[TBL] [Abstract][Full Text] [Related]
13. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
Michelini Z; Negri DR; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
J Med Primatol; 2004 Oct; 33(5-6):251-61. PubMed ID: 15525326
[TBL] [Abstract][Full Text] [Related]
14. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques.
Schadeck EB; Sidhu M; Egan MA; Chong SY; Piacente P; Masood A; Garcia-Hand D; Cappello S; Roopchand V; Megati S; Quiroz J; Boyer JD; Felber BK; Pavlakis GN; Weiner DB; Eldridge JH; Israel ZR
Vaccine; 2006 May; 24(21):4677-87. PubMed ID: 16288822
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys.
Barouch DH; Letvin NL
Dev Biol (Basel); 2000; 104():85-92. PubMed ID: 11713828
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylaxis against AIDS in macaques with a lentiviral DNA vaccine.
Liu Z; Singh DK; Sheffer D; Smith MS; Dhillon S; Chebloune Y; Hegde R; Buch S; Narayan O
Virology; 2006 Aug; 351(2):444-54. PubMed ID: 16650448
[TBL] [Abstract][Full Text] [Related]
17. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid.
Boyer JD; Robinson TM; Kutzler MA; Vansant G; Hokey DA; Kumar S; Parkinson R; Wu L; Sidhu MK; Pavlakis GN; Felber BK; Brown C; Silvera P; Lewis MG; Monforte J; Waldmann TA; Eldridge J; Weiner DB
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18648-53. PubMed ID: 18000037
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
19. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
Iida T; Kuwata T; Ui M; Suzuki H; Miura T; Ibuki K; Takahashi H; Yamamoto T; Imanishi J; Hayami M; Kita M
Arch Virol; 2004 Apr; 149(4):743-57. PubMed ID: 15045561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
